Earnings
NRBO
3.920
-1.75%
-0.070
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
13.91M
--
--
--
--
--
0.00
--
--
--
153.00K
57.00K
14.12M
350.00K
--
--
--
--
158.00K
--
--
350.00K
14.47M
--
638.00K
0.00
--
--
--
--
--
1.44M
--
--
--
--
2.08M
0.00
--
--
--
94.00K
94.00K
2.18M
16.00K
49.13M
-36.87M
--
--
--
12.29M
12.29M
14.47M
FY 2018-12-31
18.95M
--
--
--
--
--
0.00
--
--
--
715.00K
17.00K
19.69M
8000.00
--
--
--
--
--
--
8000.00
8000.00
19.69M
--
2.04M
0.00
--
--
--
--
--
438.00K
--
--
--
--
11.92M
0.00
--
--
--
1000.00
1000.00
11.92M
22.00K
91.86M
-84.11M
--
--
--
7.77M
7.77M
19.69M
FY 2017-12-31
18.47M
--
--
--
--
--
0.00
--
--
--
490.00K
46.00K
19.01M
8000.00
--
--
--
--
--
--
8000.00
8000.00
19.02M
--
4.03M
0.00
--
--
--
--
--
1.01M
--
--
--
--
6.39M
8.68M
--
--
--
3000.00
8.69M
15.08M
18.00K
64.40M
-60.47M
--
--
--
3.94M
3.94M
19.02M
FY 2016-12-31
24.03M
--
--
--
--
--
0.00
--
--
--
713.00K
--
24.75M
8000.00
--
--
--
--
--
--
8000.00
8000.00
24.75M
--
2.01M
0.00
--
--
--
--
--
2.11M
--
--
--
0.00
4.12M
0.00
--
--
--
1000.00
1000.00
4.12M
17.00K
47.67M
-27.06M
--
--
--
20.63M
20.63M
24.75M
FY 2015-12-31
3.62M
--
--
--
--
--
0.00
--
--
--
23.00K
--
3.64M
--
--
--
--
--
--
--
847.00K
847.00K
4.49M
--
531.00K
6.42M
--
--
--
--
--
1.62M
--
--
--
345.00K
8.92M
0.00
--
--
--
--
0.00
8.92M
12.00K
0.00
-12.39M
--
--
--
-4.43M
-4.43M
4.49M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NRBO latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze NeuroBo Pharmaceuticals Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.